advertisement
Abstract #91905 Published in IGR 22-1
Glaucoma
Kang JM; Tanna APThe Medical clinics of North America 2021; 105: 493-510
Glaucoma is the leading cause of irreversible blindness worldwide. The global prevalence of glaucoma in people aged 40 to 80 years is estimated to be 3.5%. With the growing number and proportion of older persons in the population, it is projected that 111.8 million people will have glaucoma in 2040. Currently available treatments cannot reverse glaucomatous damage to the visual system; however, early diagnosis and treatment can prevent progression of the disease. In most cases, glaucoma is a chronic condition that requires lifelong management. This article reviews the pathophysiology, classification, clinical manifestations, diagnosis, and management of glaucoma.
Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Full articleClassification:
1.3 Pathogenesis (Part of: 1 General aspects)
11.1 General management, indication (Part of: 11 Medical treatment)
12.1 General management, indication (Part of: 12 Surgical treatment)
6.1 Intraocular pressure measurement; factors affecting IOP (Part of: 6 Clinical examination methods)
